Basilea Pharmaceutica AG (BSLN) — Free Cash Flow Generation Index
Basilea Pharmaceutica AG (BSLN) has a Free Cash Flow Generation Index of 0.94x as of December 2025. Free cash flow of CHF36.73 Million represents 1% of operating cash flow (CHF39.03 Million). See Basilea Pharmaceutica AG working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Basilea Pharmaceutica AG Free Cash Flow Generation Index (2005–2025)
Historical FCF Generation Index trend for Basilea Pharmaceutica AG across 8 annual periods. Explore how well can Basilea Pharmaceutica AG service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Basilea Pharmaceutica AG (2005–2025)
Year-by-year Free Cash Flow Generation Index for Basilea Pharmaceutica AG. For the full company profile including market capitalisation, see Basilea Pharmaceutica AG (BSLN) total market value.
| Year | FCG Index | Free Cash Flow (CHF) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | CHF59.47 Million | CHF62.09 Million | CHF2.62 Million | ▼ -2.0% |
| 2024 | 0.98x | CHF72.65 Million | CHF74.36 Million | CHF1.71 Million | ▲ +5.3% |
| 2023 | 0.93x | CHF13.21 Million | CHF14.24 Million | CHF1.03 Million | ▲ +74.4% |
| 2022 | 0.53x | CHF3.75 Million | CHF7.06 Million | CHF3.30 Million | ▼ -44.7% |
| 2017 | 0.96x | CHF18.30 Million | CHF19.01 Million | CHF711.00K | ▼ -2.9% |
| 2012 | 0.99x | CHF146.85 Million | CHF148.17 Million | CHF1.32 Million | ▲ +0.3% |
| 2010 | 0.99x | CHF105.40 Million | CHF106.64 Million | CHF1.24 Million | ▲ +2.4% |
| 2005 | 0.97x | CHF33.18 Million | CHF34.38 Million | CHF1.20 Million | — |